MLEC vs. MNTN, ESHA, LFT, GATE, BMAC, IRRX, PLAO, RILY, SRL, and SIEB
Should you be buying Moolec Science stock or one of its competitors? The main competitors of Moolec Science include Everest Consolidator Acquisition (MNTN), ESH Acquisition (ESHA), Lument Finance Trust (LFT), Marblegate Acquisition (GATE), Black Mountain Acquisition (BMAC), Integrated Rail and Resources Acquisition (IRRX), Patria Latin American Opportunity Acquisition (PLAO), B. Riley Financial (RILY), Scully Royalty (SRL), and Siebert Financial (SIEB). These companies are all part of the "trading" industry.
Moolec Science vs.
Everest Consolidator Acquisition (NYSE:MNTN) and Moolec Science (NASDAQ:MLEC) are both small-cap unclassified companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.
Everest Consolidator Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Moolec Science has a beta of -0.47, suggesting that its stock price is 147% less volatile than the S&P 500.
Everest Consolidator Acquisition has higher earnings, but lower revenue than Moolec Science.
Everest Consolidator Acquisition has a net margin of 0.00% compared to Moolec Science's net margin of -129.97%. Everest Consolidator Acquisition's return on equity of 0.00% beat Moolec Science's return on equity.
Moolec Science received 3 more outperform votes than Everest Consolidator Acquisition when rated by MarketBeat users.
In the previous week, Everest Consolidator Acquisition and Everest Consolidator Acquisition both had 1 articles in the media. Everest Consolidator Acquisition's average media sentiment score of 0.00 equaled Moolec Science'saverage media sentiment score.
72.9% of Everest Consolidator Acquisition shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 60.3% of Everest Consolidator Acquisition shares are held by company insiders. Comparatively, 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Moolec Science has a consensus price target of $6.00, suggesting a potential upside of 658.53%. Given Moolec Science's stronger consensus rating and higher probable upside, analysts plainly believe Moolec Science is more favorable than Everest Consolidator Acquisition.
Summary
Everest Consolidator Acquisition beats Moolec Science on 6 of the 11 factors compared between the two stocks.
Get Moolec Science News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Moolec Science Competitors List
Related Companies and Tools
This page (NASDAQ:MLEC) was last updated on 1/21/2025 by MarketBeat.com Staff
Free MLEC Stock Alerts